跳至主要内容
临床试验/NCT01954602
NCT01954602已完成不适用

A Multicenter Randomized Trial Comparing the Use of Touch and no Touch Guide-wire Techniques for Deep Biliary Cannulation: the TNT Study

Azienda Usl di Bologna1 个研究点 分布在 1 个国家目标入组 206 人开始时间: 2013年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
206
试验地点
1
主要终点
Cannulation success rate

研究概览

简要总结

The specific goal of this study is to compare the deep biliary cannulation rate and complication rates associated with use of touch and no touch guide-wire biliary cannulation techniques.

详细描述

The most common technique used to achieve primary deep biliary cannulation is the standard contrast-assisted method, in which a catheter or sphincterotome is introduced into the papilla in the direction of the bile duct and a contrast medium injected to confirm that the duct has been cannulated.

The biliary guidewire cannulation technique consists of the introduction of a guide-wire into the bile duct instead of contrast injection as the first maneuver.

The benefit of this technique, compared with classic contrast cannulation, has been demonstrated in several studies which show similar results and have been analyzed in a recent meta-analysis, including 5 studies and 1762 patients, and demonstrating that the use of the guide-wire technique significantly improved the primary cannulation rate from 74.9% to 85.3%. More importantly, significantly reduced the incidence of PEP from 8.6% to 1.6%.

There are several variations of this technique; the tip of the sphincterotome is inserted initially a few millimeters through the papillary orifice and then introduce the guide-wire to the target ("touch technique"). Another variation is direct cannulation with the guide-wire hovering a few millimeters through the catheter or sphincterotome ("no touch technique").

To date, there are no randomized controlled trials comparing the two above described way to access to biliary duct regarding efficacy and rate of complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 18 or older
  • •Clinical symptoms, laboratory findings and radiological evidences of biliary disease
  • •Willing and able to comply with the study procedures and provide written informed consent to participate in the study

排除标准

  • •Age <18 yars
  • •Patients with previous sphincterotomy
  • •Patients with previous papillary endoscopic balloon dilation
  • •Presence of a previously placed plastic or metal biliary stent
  • •Presence of any esophageal or gastro/duodenal stent
  • •Pancreatic or ampullary cancer, proven by imaging and/or cytology and/or histology, are excluded as PEP is very uncommon in these subgroups and tumour-related anatomical variation may alter cannulation technique (consider substratify results for this subgroup, but exclude if duodenal stenosis precludes an attempt on the papilla)
  • •Patients with surgically altered anatomy (Bilroth II gastrectomy and Roux en Y anastomosis) are excluded as cannulation technique is fundamentally different from that in normal anatomy
  • •Presence of a diverticular papilla
  • •Presence of a duodenal stenosis
  • •Presence of a pancreas divisum
  • •Patients with contraindication to endoscopic procedures
  • •Hemodinynamic instability, any acute illness or exacerbation of chronic illness, acute infections.
  • •Platelet count less than 50,000/mm3 and INR no greater than 1.5 times upper limit of normal
  • •Inability or refusal to give informed consent.
  • •Refusal to provide consent

研究组 & 干预措施

Touch group

Active Comparator

Sphincterotome assisted guide-wire cannulation

干预措施: Sphincterotome assisted guide-wire cannulation (Procedure)

No touch group

Experimental

Guide-wire cannulation

干预措施: Guide-wire cannulation (Procedure)

结局指标

主要结局

Cannulation success rate

时间窗: No more than 5 minutes of biliary cannulation or 5 unintended pancreatic duct cannulation with the guidewire, with both techniques

次要结局

  • Incidences of PEP(from the intervention until two days)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

CARLO DESCOVICH

Medical Doctor

Azienda Usl di Bologna

研究点 (1)

Loading locations...

相似试验